October 26, 2026

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics: Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images and Generate Scalable Insights into Tumor Microenvironment Biology  Seoul, South Korea and Miami, Florida, October 23, 2026 – Lunit Inc....

recent articles

Optra Systems today announced the launch of their highly affordable On-Demand Pay-Per-Usage model for its OptraSCANTM Whole Slide Imaging system and End-to-End Digital Pathology solution platform. In order to simplify their workflow, users will...

This is interesting news from Clearpath Derm, a company founded by a well-known high volume dermatopathology laboratory, Dermpath Lab of Central States (DLCS) to provide its clients with remote access to their images. In a nutshell Clearpath...

Dr. Clive Taylor is currently Professor of Pathology at University of Southern California and Editor in Chief of Applied Immunohistochemistry and Molecular Morphology. Professor Clive Taylor attended medical school at the University of...

Foundation Medicine will be exhibiting at Booth #24109 during the meeting with over 20 poster presentations and 2 oral presentations at #ASCO16. No doubt that genomic profiling, immunotherapy and liquid biopsy are going to have a huge...

More interesting news around PD-L1 for use in Classical Hodgkin lymphoma with specific indications as below. Another increasingly common example of companion diagnostics and personalized immunotherapies. On May 17, 2016, the U.S. Food and Drug...

OR

platinum partners

gold partners

Silver Partners

Media Partners